Ann: Appendix 4E and 30 June 2018 Annual Report to shareholders, page-4

Agree with positive report, but think it's certainly got upside sp potential from here. All directors and management have healthy skin in the game and growth hasn't been a one off, but a regular theme. Management strategies are consistently improving bottom line and filtering into dividends, fully franked. Management are beating forecasts and I expect strategies to be announced which will further grow the company in line with their national Multiplatform marketing campaign. Kme has the runs on the board and a bankable formguide which to me oozes positivity going forward. I hold after buying at higher sp than seemed prudent two months ago and will continue to hold at least until the next interim dividend which I expect to be bigger again and will justify a share price even higher than presently. Companies growing consistently are a mainstay of my super.